Metraipolis › archive › dc_05f91530bc3f

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies — Europe PMC PMID:42381708

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42381708
DOI
10.1016/j.omtn.2026.102976
License (as archived)
solo-consultazione
Archived
2026-10-31T16:24:09.497Z
SHA-256 of the archived text
33290b873265083573af1dfd64b181c08a460eabaf2613a3246591db45aec929
Stable URL of this page
https://metraipolis.com/documento/dc_05f91530bc3f

How to cite

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies — Europe PMC PMID:42381708 — Europe PMC (en), https://europepmc.org/article/MED/42381708 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05f91530bc3f (Metraipolis archive dc_05f91530bc3f, sha256 33290b873265083573af1dfd64b181c08a460eabaf2613a3246591db45aec929)
BibTeX
@misc{dc05f91530bc3f,
  title = {Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies — Europe PMC PMID:42381708},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42381708},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05f91530bc3f; sha256 33290b873265083573af1dfd64b181c08a460eabaf2613a3246591db45aec929},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42381708. Agents can read the archived copy with the MCP tool read_document.